Hadassah

Hadassah Surgeons Trained in Groundbreaking Surgical Technique for Removing Cancerous Tumors

Thursday, Dec 15 2011

An innovative procedure to remove cancerous tumors from a patient's gastrointestinal tract has been introduced at the Hadassah University Medical Center's Institute of Gastroenterology and Liver Diseases by Prof. Hans- Wolf Sievert, head of Gastroenterology at Germany's Oldenburg-University Hospital and a renowned expert in this field.

With special instruments inserted through an endoscope--a surgical tool used to examine body cavities--surgeons "peeled" the lesion from the gastrointestinal wall. "While the procedure was a Hadassah 'first,' as is our practice, we believe in sharing our knowledge for the benefit of all our patients," said Prof. Ran Oren, Director of the Institute of Gastroenterology and Liver Diseases. Therefore, Hadassah convened a two-day workshop for gastroenterology and liver experts from throughout Israel. Prof. Sievert keynoted the proceedings with the active participation of two of the physicians from Hadassah's Institute of Gastroenterology and Liver Diseases---Dr. Yael Kopelman, Director of the Endoscopy Unit, and Dr. Harold Jacob—as well as Dr. Yoav Mintz, Director of Hadassah's Center for Innovative Surgery.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More